Follow The Filings

ZLAB Zai Lab Ltd.

Health Care, filed as ZAI LAB LTD (ADR), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.1%
  • $31M
  • 1 reduce

In 2026 Q2 Ron Baron trimmed Zai Lab.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Ron Baron, Bamco Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Reduce 0.05%

Who owns ZLAB

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.05%, was 0.10% Reduce −2.1% 1,623,694 $31M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ZLAB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ZLAB insider trades
  • $66K bought by 1 insider
  • None no sales outside a trading plan
  • $9.2M sold by 5 insiders under 10b5-1 plans
  1. Yajing Chen CFO
    Planned sale
    $7,020 260 shares at $27.00 0.7% of stake
    Traded Aug 19 Filed Aug 21
    ↗
  2. William Lis Director
    Planned sale
    $213K 8,506 shares at $25.00 17% of stake
    Traded Aug 12 Filed Aug 13
    ↗
  3. Yajing Chen CFO
    Planned sale
    $15K 619 shares at $25.00 1.7% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  4. Richard Gaynor Director
    Buy
    $33K 1,736 shares at $19.05 +2.2% to stake
    Traded Jul 1 Filed Jul 6
    ↗
  5. William Lis Director
    Planned sale
    $127K 7,040 shares at $18.09 12% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  6. Du Ying CEO
    Planned sale
    $2M 100,000 shares at $19.87 8.2% of stake
    Traded May 15–18 Filed May 19
    ↗
  7. Frazor Titus Edmondson III Chief Legal Officer
    Planned sale
    $71K 3,517 shares at $20.19 15% of stake
    Traded May 14 Filed May 15
    ↗
  8. Du Ying CEO
    Planned sale
    $2M 100,000 shares at $20.03 8.2% of stake
    Traded May 13–14 Filed May 15
    ↗
  9. Richard Gaynor Director
    Buy
    $33K 1,731 shares at $18.91 +3.2% to stake
    Traded Mar 17 Filed Mar 19
    ↗
  10. Du Ying CEO
    Planned sale
    $1.9M 100,000 shares at $19.22 9.4% of stake
    Traded Mar 6–9 Filed Mar 10
    ↗
  11. Frazor Titus Edmondson III Chief Legal Officer
    Planned sale
    $297K 15,569 shares at $19.06 82% of stake
    Traded Mar 5 Filed Mar 6
    ↗
  12. Du Ying CEO
    Planned sale
    $1.9M 100,000 shares at $19.19 9.4% of stake
    Traded Mar 4–5 Filed Mar 6
    ↗
  13. Rafael Amado See Remarks
    Planned sale
    $174K 10,000 shares at $17.38 19% of stake
    Traded Mar 3 Filed Mar 5
    ↗
  14. Frazor Titus Edmondson III Chief Legal Officer
    Planned sale
    $148K 8,651 shares at $17.14 31% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  15. Frazor Titus Edmondson III Chief Legal Officer
    Planned sale
    $283K 14,328 shares at $19.78 34% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 39 option exercises, 21 sales to cover taxes, 8 stock grants, 6 share withholdings for taxes, and 5 gifts.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 1.01,3.02,7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated about 3 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $266.72M $397.61M $457.18M
Gross profit * $170.9M — —
Gross margin * 64.1% — —
Net income -$334.62M -$257.1M -$175.54M
Net margin * -125.5% -64.7% -38.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.94B $1.05B $1.02B
Total non-current assets * $96.69M $135.27M $153.1M
Total assets $1.04B $1.19B $1.17B
Total current liabilities $203.07M $299.38M $416.17M
Total non-current liabilities * $37.11M $45.47M $40.72M
Total equity $796.12M $840.9M $715.5M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$198.18M -$214.87M -$150.79M
Cash from investing -$10.78M -$375.19M $307.87M
Cash from financing -$6.43M $349.89M $72.35M
Net change in cash -$218.01M -$240.48M $229.91M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.